InvestorsHub Logo
icon url

Sub Atomic master

12/01/15 6:21 PM

#46196 RE: gnawkz #46190

actually, i have what i think is a good question,who is the professional scientist or head of cognate who knows and does all this setting up,and the building of all of our new systems,whats his or her experience,etc.
icon url

sentiment_stocks

12/01/15 7:12 PM

#46202 RE: gnawkz #46190

I read the later post first, then this one. I think you've answered my question but if you want to elaborate, that'd be great.

I'm curious to find out if that $14 million we've paid to Cognate for taking care of points 2 through 6 could basically have been covered by the locked up and unregistered shares the Company paid them.

The shares that are not part of our float at this time.

The shares that were traded as payment for work that the Company then did not have to finance.

The shares that had Cognate not accepted that shares for work deal would have instead resulted in some terrible new financing arrangement to some horrible hedge fund for another horrendous deal (until of course, The Woodford came along).

If so, then it could be said that for now, we sorta didn't pay anything for all that extra good STUFF. :)
icon url

austinmediainc

12/01/15 8:58 PM

#46216 RE: gnawkz #46190

We actually really don't kow what Cognate is responsible for, what they are being paid for, and lastley what remains NWBO's and what is Cognate's at the end of it all. If you prefer it that way then that is your opinion, I would rather own the assests and be in total control of my business moving forward, but then that's my opinion. My comparison wasn't solely based on the manufacturing and scale up, it was on the treatment, trial stage, trial size, enrollment, etc. The fact tht they are preparing to scale up for approval in their own building with their own machines was secondary but still pretty similar if you ask me.